These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
90-0199783
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
1275 Market Street
San Francisco, CA
|
94103-1410
|
(415) 558-0200
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer
ý
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
¨
|
|
|
|
Emerging growth company
¨
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
|
||
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
||
|
Abbreviation
|
|
Term
|
|
AAC
|
|
Advanced Audio Coding
|
|
AFS
|
|
Available-For-Sale (Securities)
|
|
AOCI
|
|
Accumulated Other Comprehensive Income
|
|
APIC
|
|
Additional-Paid In-Capital
|
|
ASC
|
|
Accounting Standards Codification
|
|
ASP
|
|
Average Selling Price
|
|
ASU
|
|
Accounting Standards Update
|
|
ATSC
|
|
Advanced Television Systems Committee
|
|
AVR
|
|
Audio/Video Receiver
|
|
CE
|
|
Consumer Electronics
|
|
CODM
|
|
Chief Operating Decision Maker
|
|
COGS
|
|
Cost Of Goods Sold
|
|
COSO
|
|
Committee Of Sponsoring Organizations (Of The Treadway Commission)
|
|
DD
|
|
Dolby Digital®
|
|
DD+
|
|
Dolby Digital Plus™
|
|
DMA
|
|
Digital Media Adapter
|
|
DTV
|
|
Digital Television
|
|
DVB
|
|
Digital Video Broadcasting
|
|
DVD
|
|
Digital Versatile Disc
|
|
EPS
|
|
Earnings Per Share
|
|
ESP
|
|
Estimated Selling Price
|
|
ESPP
|
|
Employee Stock Purchase Plan
|
|
FASB
|
|
Financial Accounting Standards Board
|
|
FCPA
|
|
Foreign Corrupt Practices Act
|
|
FIFO
|
|
First-in, First-out
|
|
G&A
|
|
General & Administrative
|
|
HDR
|
|
High-Dynamic Range
|
|
HDTV
|
|
High Definition Television
|
|
HE AAC
|
|
High Efficiency Advanced Audio Coding
|
|
HEVC
|
|
High Efficiency Video Coding
|
|
HFR
|
|
High Frame Rate
|
|
HTIB
|
|
Home Theater In-A-Box
|
|
IC
|
|
Integrated Circuit
|
|
IMB
|
|
Integrated Media Block
|
|
IP
|
|
Intellectual Property
|
|
IPO
|
|
Initial Public Offering
|
|
IPTV
|
|
Internet Protocol Television
|
|
IT
|
|
Information Technology
|
|
LCD
|
|
Liquid Crystal Display
|
|
LIFO
|
|
Last-in, Last-out
|
|
LP
|
|
Limited Partner/Partnership
|
|
ME
|
|
Multiple Element
|
|
NOL
|
|
Net Operating Loss
|
|
OCI
|
|
Other Comprehensive Income
|
|
ODD
|
|
Optical Disc Drive
|
|
OECD
|
|
Organization For Economic Co-Operation & Development
|
|
OEM
|
|
Original Equipment Manufacturer
|
|
OLED
|
|
Organic Light-Emitting Diode
|
|
OTT
|
|
Over-The-Top
|
|
PC
|
|
Personal Computer
|
|
PCS
|
|
Post-Contract Support
|
|
PP&E
|
|
Property, Plant And Equipment
|
|
PSO
|
|
Performance-Based Stock Option
|
|
R&D
|
|
Research & Development
|
|
RSU
|
|
Restricted Stock Unit
|
|
S&M
|
|
Sales & Marketing
|
|
SERP
|
|
Supplemental Executive Retirement Plan
|
|
SoC
|
|
System(s)-On-A-Chip
|
|
STB
|
|
Set-Top Box
|
|
TAM
|
|
Total Available Market
|
|
TPE
|
|
Third Party Evidence
|
|
TSR
|
|
Total Stockholder Return
|
|
UHD
|
|
Ultra High Definition
|
|
U.S. GAAP
|
|
Generally Accepted Accounting Principles In The United States
|
|
VSOE
|
|
Vendor Specific Objective Evidence
|
|
|
March 31,
2017 |
September 30,
2016 |
||||
|
ASSETS
|
(unaudited)
|
|
||||
|
Current assets:
|
|
|
||||
|
Cash and cash equivalents
|
$
|
532,508
|
|
$
|
516,112
|
|
|
Restricted cash
|
5,752
|
|
3,645
|
|
||
|
Short-term investments
|
194,997
|
|
121,629
|
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $3,258 and $2,370
|
88,216
|
|
75,688
|
|
||
|
Inventories
|
17,697
|
|
16,354
|
|
||
|
Prepaid expenses and other current assets
|
32,501
|
|
26,302
|
|
||
|
Total current assets
|
871,671
|
|
759,730
|
|
||
|
Long-term investments
|
326,800
|
|
393,904
|
|
||
|
Property, plant and equipment, net
|
471,095
|
|
443,656
|
|
||
|
Intangible assets, net
|
203,723
|
|
215,342
|
|
||
|
Goodwill
|
308,751
|
|
309,616
|
|
||
|
Deferred taxes
|
176,288
|
|
166,790
|
|
||
|
Other non-current assets
|
29,469
|
|
21,068
|
|
||
|
Total assets
|
$
|
2,387,797
|
|
$
|
2,310,106
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
||||
|
Current liabilities:
|
|
|
||||
|
Accounts payable
|
$
|
10,062
|
|
$
|
17,544
|
|
|
Accrued liabilities
|
179,029
|
|
169,055
|
|
||
|
Income taxes payable
|
25
|
|
2,304
|
|
||
|
Deferred revenue
|
23,940
|
|
24,180
|
|
||
|
Total current liabilities
|
213,056
|
|
213,083
|
|
||
|
Long-term deferred revenue
|
35,651
|
|
35,366
|
|
||
|
Other non-current liabilities
|
95,932
|
|
82,922
|
|
||
|
Total liabilities
|
344,639
|
|
331,371
|
|
||
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
||||
|
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 57,702,863 shares issued and outstanding at March 31, 2017 and 57,018,362 at September 30, 2016
|
57
|
|
57
|
|
||
|
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 44,073,597 shares issued and outstanding at March 31, 2017 and 44,403,847 at September 30, 2016
|
44
|
|
44
|
|
||
|
Additional paid-in capital
|
37,459
|
|
42,032
|
|
||
|
Retained earnings
|
2,013,790
|
|
1,938,320
|
|
||
|
Accumulated other comprehensive (loss)
|
(14,708
|
)
|
(10,197
|
)
|
||
|
Total stockholders’ equity – Dolby Laboratories, Inc.
|
2,036,642
|
|
1,970,256
|
|
||
|
Controlling interest
|
6,516
|
|
8,479
|
|
||
|
Total stockholders’ equity
|
2,043,158
|
|
1,978,735
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
2,387,797
|
|
$
|
2,310,106
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Revenue:
|
|
|
|
|
|
||||||||
|
Licensing
|
$
|
241,617
|
|
$
|
249,336
|
|
|
$
|
474,316
|
|
$
|
460,465
|
|
|
Products
|
20,713
|
|
20,063
|
|
|
48,924
|
|
44,872
|
|
||||
|
Services
|
5,144
|
|
4,941
|
|
|
10,501
|
|
9,817
|
|
||||
|
Total revenue
|
267,474
|
|
274,340
|
|
|
533,741
|
|
515,154
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Cost of revenue:
|
|
|
|
|
|
||||||||
|
Cost of licensing
|
8,796
|
|
6,698
|
|
|
16,917
|
|
13,231
|
|
||||
|
Cost of products
|
13,988
|
|
13,978
|
|
|
31,708
|
|
33,016
|
|
||||
|
Cost of services
|
4,193
|
|
3,697
|
|
|
8,319
|
|
7,892
|
|
||||
|
Total cost of revenue
|
26,977
|
|
24,373
|
|
|
56,944
|
|
54,139
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Gross margin
|
240,497
|
|
249,967
|
|
|
476,797
|
|
461,015
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating expenses:
|
|
|
|
|
|
||||||||
|
Research and development
|
58,341
|
|
52,088
|
|
|
115,859
|
|
105,416
|
|
||||
|
Sales and marketing
|
75,620
|
|
71,815
|
|
|
146,795
|
|
146,269
|
|
||||
|
General and administrative
|
43,253
|
|
42,482
|
|
|
84,793
|
|
86,560
|
|
||||
|
Restructuring charges
|
—
|
|
1,255
|
|
|
—
|
|
1,255
|
|
||||
|
Total operating expenses
|
177,214
|
|
167,640
|
|
|
347,447
|
|
339,500
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating income
|
63,283
|
|
82,327
|
|
|
129,350
|
|
121,515
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Other income/expense:
|
|
|
|
|
|
||||||||
|
Interest income
|
2,186
|
|
1,250
|
|
|
4,000
|
|
2,547
|
|
||||
|
Interest expense
|
(37
|
)
|
(33
|
)
|
|
(63
|
)
|
(62
|
)
|
||||
|
Other income/(expense), net
|
762
|
|
279
|
|
|
563
|
|
(693
|
)
|
||||
|
Total other income
|
2,911
|
|
1,496
|
|
|
4,500
|
|
1,792
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income before income taxes
|
66,194
|
|
83,823
|
|
|
133,850
|
|
123,307
|
|
||||
|
Provision for income taxes
|
(15,467
|
)
|
(16,278
|
)
|
|
(29,549
|
)
|
(24,751
|
)
|
||||
|
Net income including controlling interest
|
50,727
|
|
67,545
|
|
|
104,301
|
|
98,556
|
|
||||
|
Less: net (income) attributable to controlling interest
|
(137
|
)
|
(147
|
)
|
|
(337
|
)
|
(257
|
)
|
||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
50,590
|
|
$
|
67,398
|
|
|
$
|
103,964
|
|
$
|
98,299
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per share:
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.50
|
|
$
|
0.67
|
|
|
$
|
1.02
|
|
$
|
0.98
|
|
|
Diluted
|
$
|
0.49
|
|
$
|
0.66
|
|
|
$
|
1.00
|
|
$
|
0.97
|
|
|
Weighted-average shares outstanding:
|
|
|
|
|
|
||||||||
|
Basic
|
101,787
|
|
100,456
|
|
|
101,635
|
|
100,600
|
|
||||
|
Diluted
|
103,883
|
|
101,555
|
|
|
103,867
|
|
101,716
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Related party rent expense:
|
|
|
|
|
|
||||||||
|
Included in operating expenses
|
$
|
793
|
|
$
|
756
|
|
|
$
|
1,575
|
|
$
|
1,537
|
|
|
Included in net income attributable to controlling interest
|
$
|
175
|
|
$
|
174
|
|
|
$
|
350
|
|
$
|
350
|
|
|
|
|
|
|
|
|
||||||||
|
Cash dividend declared per common share
|
$
|
0.14
|
|
$
|
0.12
|
|
|
$
|
0.28
|
|
$
|
0.24
|
|
|
Cash dividend paid per common share
|
$
|
0.14
|
|
$
|
0.12
|
|
|
$
|
0.28
|
|
$
|
0.24
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Net income including controlling interest
|
$
|
50,727
|
|
$
|
67,545
|
|
|
$
|
104,301
|
|
$
|
98,556
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
||||||
|
Currency translation adjustments, net of tax
|
4,445
|
|
2,872
|
|
|
(3,279
|
)
|
2,122
|
|
||||
|
Unrealized gains/(losses) on investments, net of tax
|
581
|
|
1,563
|
|
|
(1,438
|
)
|
703
|
|
||||
|
Comprehensive income
|
55,753
|
|
71,980
|
|
|
99,584
|
|
101,381
|
|
||||
|
Less: comprehensive (income)/loss attributable to controlling interest
|
(192
|
)
|
(1
|
)
|
|
(131
|
)
|
38
|
|
||||
|
Comprehensive income attributable to Dolby Laboratories, Inc.
|
$
|
55,561
|
|
$
|
71,979
|
|
|
$
|
99,453
|
|
$
|
101,419
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common
Stock
|
Additional
Paid-In Capital |
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
|
Balance at September 30, 2016
|
$
|
101
|
|
$
|
42,032
|
|
$
|
1,938,320
|
|
$
|
(10,197
|
)
|
$
|
1,970,256
|
|
$
|
8,479
|
|
$
|
1,978,735
|
|
|
Net income
|
—
|
|
—
|
|
103,964
|
|
—
|
|
103,964
|
|
337
|
|
104,301
|
|
|||||||
|
Currency translation adjustments, net of tax of $666
|
—
|
|
—
|
|
—
|
|
(3,073
|
)
|
(3,073
|
)
|
(206
|
)
|
(3,279
|
)
|
|||||||
|
Unrealized (losses) on investments, net of tax of $2
|
—
|
|
—
|
|
—
|
|
(1,438
|
)
|
(1,438
|
)
|
—
|
|
(1,438
|
)
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(2,094
|
)
|
(2,094
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
33,198
|
|
—
|
|
—
|
|
33,198
|
|
—
|
|
33,198
|
|
|||||||
|
Repurchase of common stock
|
(1
|
)
|
(49,999
|
)
|
—
|
|
—
|
|
(50,000
|
)
|
—
|
|
(50,000
|
)
|
|||||||
|
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(28,494
|
)
|
—
|
|
(28,494
|
)
|
—
|
|
(28,494
|
)
|
|||||||
|
Tax benefit from employee stock plans
|
—
|
|
3,818
|
|
—
|
|
—
|
|
3,818
|
|
—
|
|
3,818
|
|
|||||||
|
Common stock issued under employee stock plans
|
2
|
|
24,208
|
|
—
|
|
—
|
|
24,210
|
|
—
|
|
24,210
|
|
|||||||
|
Tax withholdings on vesting of restricted stock
|
(1
|
)
|
(15,798
|
)
|
—
|
|
—
|
|
(15,799
|
)
|
—
|
|
(15,799
|
)
|
|||||||
|
Balance at March 31, 2017
|
$
|
101
|
|
$
|
37,459
|
|
$
|
2,013,790
|
|
$
|
(14,708
|
)
|
$
|
2,036,642
|
|
$
|
6,516
|
|
$
|
2,043,158
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common
Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
|
Balance at September 25, 2015
|
$
|
102
|
|
$
|
17,571
|
|
$
|
1,800,857
|
|
$
|
(11,462
|
)
|
$
|
1,807,068
|
|
$
|
8,939
|
|
$
|
1,816,007
|
|
|
Net income
|
—
|
|
—
|
|
98,299
|
|
—
|
|
98,299
|
|
257
|
|
98,556
|
|
|||||||
|
Currency translation adjustments, net of tax of $188
|
—
|
|
—
|
|
—
|
|
2,417
|
|
2,417
|
|
(295
|
)
|
2,122
|
|
|||||||
|
Unrealized gains on investments, net of tax of $(17)
|
—
|
|
—
|
|
—
|
|
703
|
|
703
|
|
—
|
|
703
|
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(214
|
)
|
(214
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
35,466
|
|
—
|
|
—
|
|
35,466
|
|
—
|
|
35,466
|
|
|||||||
|
Repurchase of common stock
|
(2
|
)
|
(55,500
|
)
|
(21,354
|
)
|
—
|
|
(76,856
|
)
|
—
|
|
(76,856
|
)
|
|||||||
|
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(24,200
|
)
|
—
|
|
(24,200
|
)
|
—
|
|
(24,200
|
)
|
|||||||
|
Tax (deficiency) from employee stock plans
|
—
|
|
(1,369
|
)
|
—
|
|
—
|
|
(1,369
|
)
|
—
|
|
(1,369
|
)
|
|||||||
|
Common stock issued under employee stock plans
|
—
|
|
14,575
|
|
—
|
|
—
|
|
14,575
|
|
—
|
|
14,575
|
|
|||||||
|
Tax withholdings on vesting of restricted stock
|
1
|
|
(10,743
|
)
|
—
|
|
—
|
|
(10,742
|
)
|
—
|
|
(10,742
|
)
|
|||||||
|
Balance at April 1, 2016
|
$
|
101
|
|
$
|
—
|
|
$
|
1,853,602
|
|
$
|
(8,342
|
)
|
$
|
1,845,361
|
|
$
|
8,687
|
|
$
|
1,854,048
|
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
March 31,
2017 |
April 1,
2016 |
||||
|
Operating activities:
|
|
|
||||
|
Net income including controlling interest
|
$
|
104,301
|
|
$
|
98,556
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
|
Depreciation and amortization
|
44,061
|
|
42,917
|
|
||
|
Stock-based compensation
|
33,198
|
|
35,466
|
|
||
|
Amortization of premium on investments
|
1,376
|
|
2,661
|
|
||
|
Excess tax benefit from exercise of stock options
|
(3,981
|
)
|
(338
|
)
|
||
|
Provision for doubtful accounts
|
1,010
|
|
1,228
|
|
||
|
Deferred income taxes
|
(8,856
|
)
|
(5,709
|
)
|
||
|
Other non-cash items affecting net income
|
160
|
|
498
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
||||
|
Accounts receivable
|
(13,538
|
)
|
(1,727
|
)
|
||
|
Inventories
|
(3,253
|
)
|
(3,533
|
)
|
||
|
Prepaid expenses and other assets
|
(11,280
|
)
|
(6,979
|
)
|
||
|
Accounts payable and other liabilities
|
495
|
|
(5,939
|
)
|
||
|
Income taxes, net
|
11,089
|
|
(8,752
|
)
|
||
|
Deferred revenue
|
85
|
|
8,495
|
|
||
|
Other non-current liabilities
|
480
|
|
22
|
|
||
|
Net cash provided by operating activities
|
155,347
|
|
156,866
|
|
||
|
|
|
|
||||
|
Investing activities:
|
|
|
||||
|
Purchase of investments
|
(98,789
|
)
|
(200,944
|
)
|
||
|
Proceeds from sales of investment securities
|
23,071
|
|
227,094
|
|
||
|
Proceeds from maturities of investment securities
|
66,171
|
|
59,053
|
|
||
|
Purchases of PP&E
|
(51,230
|
)
|
(48,984
|
)
|
||
|
Purchase of intangible assets
|
(5,250
|
)
|
(105,270
|
)
|
||
|
Change in restricted cash
|
(2,107
|
)
|
(2,342
|
)
|
||
|
Net cash used in investing activities
|
(68,134
|
)
|
(71,393
|
)
|
||
|
|
|
|
||||
|
Financing activities:
|
|
|
||||
|
Proceeds from issuance of common stock
|
24,210
|
|
14,575
|
|
||
|
Repurchase of common stock
|
(50,000
|
)
|
(76,856
|
)
|
||
|
Payment of cash dividend
|
(28,494
|
)
|
(24,200
|
)
|
||
|
Distribution to controlling interest
|
(2,094
|
)
|
(214
|
)
|
||
|
Excess tax benefit from exercise of stock options
|
3,981
|
|
338
|
|
||
|
Shares repurchased for tax withholdings on vesting of restricted stock
|
(15,799
|
)
|
(10,742
|
)
|
||
|
Net cash used in financing activities
|
(68,196
|
)
|
(97,099
|
)
|
||
|
|
|
|
||||
|
Effect of foreign exchange rate changes on cash and cash equivalents
|
(2,621
|
)
|
902
|
|
||
|
Net increase/(decrease) in cash and cash equivalents
|
16,396
|
|
(10,724
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
516,112
|
|
531,926
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
532,508
|
|
$
|
521,202
|
|
|
|
|
|
||||
|
Supplemental disclosure:
|
|
|
||||
|
Cash paid for income taxes, net of refunds received
|
$
|
28,093
|
|
$
|
39,227
|
|
|
|
|
|
||||
|
Non-cash investing and financing activities:
|
|
|
||||
|
Increase/(decrease) in PP&E purchases unpaid at period-end
|
$
|
2,248
|
|
$
|
(9,592
|
)
|
|
Purchase consideration payable for acquisition
|
$
|
—
|
|
$
|
95
|
|
|
•
|
A change from recognizing our royalty-based revenue in the quarter it is reported to us by our licensees to estimating royalty-based revenue earned from our licensees’ shipments in the reporting period with subsequent adjustments recorded as the royalties are reported.
|
|
•
|
Capitalizing applicable sales commissions that are direct and incremental to obtaining a contract.
|
|
•
|
A decrease in our deferred revenue balances.
|
|
|
March 31,
2017 |
|
September 30,
2016 |
||||
|
Trade accounts receivable
|
$
|
78,755
|
|
|
$
|
66,229
|
|
|
Accounts receivable from patent administration program customers
|
12,719
|
|
|
11,829
|
|
||
|
Accounts receivable, gross
|
91,474
|
|
|
78,058
|
|
||
|
Less: allowance for doubtful accounts
|
(3,258
|
)
|
|
(2,370
|
)
|
||
|
Total
|
$
|
88,216
|
|
|
$
|
75,688
|
|
|
|
March 31,
2017 |
|
September 30,
2016 |
||||
|
Raw materials
|
$
|
3,934
|
|
|
$
|
3,526
|
|
|
Work in process
|
3,236
|
|
|
4,020
|
|
||
|
Finished goods
|
10,527
|
|
|
8,808
|
|
||
|
Total
|
$
|
17,697
|
|
|
$
|
16,354
|
|
|
|
March 31,
2017 |
|
September 30,
2016 |
||||
|
Prepaid expenses
|
$
|
17,532
|
|
|
$
|
13,440
|
|
|
Other current assets
|
10,510
|
|
|
11,578
|
|
||
|
Income tax receivable
|
4,459
|
|
|
1,284
|
|
||
|
Total
|
$
|
32,501
|
|
|
$
|
26,302
|
|
|
|
March 31,
2017 |
|
September 30,
2016 |
||||
|
Accrued royalties
|
$
|
2,144
|
|
|
$
|
1,939
|
|
|
Amounts payable to patent administration program partners
|
49,953
|
|
|
34,472
|
|
||
|
Accrued compensation and benefits
|
59,458
|
|
|
71,261
|
|
||
|
Accrued professional fees
|
7,896
|
|
|
6,528
|
|
||
|
Other accrued liabilities
|
59,578
|
|
|
54,855
|
|
||
|
Total
|
$
|
179,029
|
|
|
$
|
169,055
|
|
|
|
March 31,
2017 |
|
September 30,
2016 |
||||
|
Supplemental retirement plan obligations
|
$
|
2,694
|
|
|
$
|
2,540
|
|
|
Non-current tax liabilities
|
80,925
|
|
|
68,254
|
|
||
|
Other liabilities
|
12,313
|
|
|
12,128
|
|
||
|
Total
|
$
|
95,932
|
|
|
$
|
82,922
|
|
|
|
March 31, 2017
|
|||||||||||||||||||||
|
|
Cost
|
Unrealized
|
|
|
Estimated Fair Value
|
|||||||||||||||||
|
|
Gains
|
Losses
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash
|
$
|
522,850
|
|
|
|
$
|
522,850
|
|
|
|
|
|
||||||||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Money market funds
|
9,498
|
|
—
|
|
—
|
|
9,498
|
|
|
9,498
|
|
|
|
|||||||||
|
Corporate bonds
|
160
|
|
—
|
|
—
|
|
160
|
|
|
|
160
|
|
|
|||||||||
|
Cash and cash equivalents
|
532,508
|
|
—
|
|
—
|
|
532,508
|
|
|
9,498
|
|
160
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Certificate of deposit
(1)
|
28,318
|
|
19
|
|
(6
|
)
|
28,331
|
|
|
|
28,331
|
|
|
|||||||||
|
U.S. agency securities
|
2,715
|
|
—
|
|
(3
|
)
|
2,712
|
|
|
2,712
|
|
|
|
|||||||||
|
Commercial paper
|
15,353
|
|
5
|
|
(1
|
)
|
15,357
|
|
|
|
15,357
|
|
|
|||||||||
|
Corporate bonds
|
127,350
|
|
48
|
|
(109
|
)
|
127,289
|
|
|
|
127,289
|
|
|
|||||||||
|
Municipal debt securities
|
21,312
|
|
2
|
|
(6
|
)
|
21,308
|
|
|
|
21,308
|
|
|
|||||||||
|
Short-term investments
|
195,048
|
|
74
|
|
(125
|
)
|
194,997
|
|
|
2,712
|
|
192,285
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Certificate of deposit
(1)
|
6,230
|
|
—
|
|
(2
|
)
|
6,228
|
|
|
|
6,228
|
|
|
|||||||||
|
U.S. agency securities
|
24,809
|
|
—
|
|
(217
|
)
|
24,592
|
|
|
24,592
|
|
|
|
|||||||||
|
Government bonds
|
22,994
|
|
4
|
|
(197
|
)
|
22,801
|
|
|
22,801
|
|
|
|
|||||||||
|
Corporate bonds
|
228,406
|
|
322
|
|
(795
|
)
|
227,933
|
|
|
|
227,933
|
|
|
|||||||||
|
Municipal debt securities
|
41,592
|
|
52
|
|
(57
|
)
|
41,587
|
|
|
|
41,587
|
|
|
|||||||||
|
Other long-term investments
(2)
|
3,282
|
|
377
|
|
—
|
|
3,659
|
|
|
377
|
|
|
|
|
||||||||
|
Long-term investments
|
327,313
|
|
755
|
|
(1,268
|
)
|
326,800
|
|
|
47,770
|
|
275,748
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total cash, cash equivalents, and investments
|
$
|
1,054,869
|
|
$
|
829
|
|
$
|
(1,393
|
)
|
$
|
1,054,305
|
|
|
$
|
59,980
|
|
$
|
468,193
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Investments held in supplemental retirement plan:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Assets
|
2,792
|
|
|
|
2,792
|
|
|
2,792
|
|
|
|
|||||||||||
|
Included in prepaid expenses and other current assets & other non-current assets
|
|
|
|
|
|
|||||||||||||||||
|
Liabilities
|
2,792
|
|
|
|
2,792
|
|
|
2,792
|
|
|
|
|||||||||||
|
Included in accrued liabilities & other non-current liabilities
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of
March 31, 2017
are classified within long-term investments.
|
|
(2)
|
Other long-term investments as of
March 31, 2017
include a marketable equity security of
$0.4 million
, and other investments that are not carried at fair value including an equity method investment of
$0.8 million
and two cost method investments of
$2.0 million
and
$0.5 million
.
|
|
|
September 30, 2016
|
|||||||||||||||||||||
|
|
Cost
|
Unrealized
|
|
|
Estimated Fair Value
|
|||||||||||||||||
|
|
Gains
|
Losses
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash
|
$
|
501,863
|
|
|
|
$
|
501,863
|
|
|
|
|
|
||||||||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Commercial paper
|
1,099
|
|
—
|
|
—
|
|
1,099
|
|
|
|
1,099
|
|
|
|||||||||
|
Corporate bonds
|
2,240
|
|
—
|
|
—
|
|
2,240
|
|
|
|
2,240
|
|
|
|||||||||
|
Money market funds
|
10,910
|
|
—
|
|
—
|
|
10,910
|
|
|
10,910
|
|
|
|
|||||||||
|
Cash and cash equivalents
|
516,112
|
|
—
|
|
—
|
|
516,112
|
|
|
10,910
|
|
3,339
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Certificate of deposit
(1)
|
13,912
|
|
6
|
|
—
|
|
13,918
|
|
|
|
13,918
|
|
|
|||||||||
|
Commercial paper
|
19,629
|
|
1
|
|
(10
|
)
|
19,620
|
|
|
|
19,620
|
|
|
|||||||||
|
Corporate bonds
|
63,762
|
|
24
|
|
(14
|
)
|
63,772
|
|
|
|
63,772
|
|
|
|||||||||
|
Municipal debt securities
|
24,334
|
|
—
|
|
(15
|
)
|
24,319
|
|
|
|
24,319
|
|
|
|||||||||
|
Short-term investments
|
121,637
|
|
31
|
|
(39
|
)
|
121,629
|
|
|
—
|
|
121,629
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Certificate of deposit
(1)
|
4,500
|
|
10
|
|
—
|
|
4,510
|
|
|
|
4,510
|
|
|
|||||||||
|
U.S. agency securities
|
27,536
|
|
24
|
|
(26
|
)
|
27,534
|
|
|
27,534
|
|
|
|
|||||||||
|
Government bonds
|
31,971
|
|
77
|
|
(12
|
)
|
32,036
|
|
|
32,036
|
|
|
|
|||||||||
|
Corporate bonds
|
295,921
|
|
715
|
|
(266
|
)
|
296,370
|
|
|
|
296,370
|
|
|
|||||||||
|
Municipal debt securities
|
30,090
|
|
28
|
|
(32
|
)
|
30,086
|
|
|
|
30,086
|
|
|
|||||||||
|
Other long-term investments
(2)
|
3,002
|
|
366
|
|
—
|
|
3,368
|
|
|
366
|
|
|
|
|||||||||
|
Long-term investments
|
393,020
|
|
1,220
|
|
(336
|
)
|
393,904
|
|
|
59,936
|
|
330,966
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total cash, cash equivalents, and investments
|
$
|
1,030,769
|
|
$
|
1,251
|
|
$
|
(375
|
)
|
$
|
1,031,645
|
|
|
$
|
70,846
|
|
$
|
455,934
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Investments held in supplemental retirement plan:
|
|
|
|
|
|
|
|
|||||||||||||||
|
Assets
|
2,638
|
|
|
|
2,638
|
|
|
2,638
|
|
|
|
|||||||||||
|
Included in prepaid expenses and other current assets & other non-current assets
|
|
|
|
|
|
|||||||||||||||||
|
Liabilities
|
2,638
|
|
|
|
2,638
|
|
|
2,638
|
|
|
|
|||||||||||
|
Included in accrued liabilities & other non-current liabilities
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
Certificates of deposit include marketable securities, while those with a maturity in excess of one year as of
September 30, 2016
are classified within long-term investments.
|
|
(2)
|
Other long-term investments as of
September 30, 2016
include a marketable equity security of
$0.4 million
, and other investments that are not carried at fair value including an equity method investment of
$0.5 million
and two cost method investments of
$2.0 million
and
$0.5 million
.
|
|
|
March 31, 2017
|
|
September 30, 2016
|
||||||||||||||||||||||
|
|
Less Than 12 Months
|
12 Months Or Greater
|
|
Less Than 12 Months
|
12 Months Or Greater
|
||||||||||||||||||||
|
Investment Type
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
|
Fair Value
|
Gross Unrealized Losses
|
Fair Value
|
Gross Unrealized Losses
|
||||||||||||||||
|
Certificate of deposit
|
$
|
14,412
|
|
$
|
(8
|
)
|
$
|
—
|
|
$
|
—
|
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
|
U.S. agency securities
|
27,304
|
|
(220
|
)
|
—
|
|
—
|
|
|
22,988
|
|
(38
|
)
|
—
|
|
—
|
|
||||||||
|
Government bonds
|
19,799
|
|
(197
|
)
|
—
|
|
—
|
|
|
—
|
|
—
|
|
—
|
|
—
|
|
||||||||
|
Commercial paper
|
4,951
|
|
(1
|
)
|
—
|
|
—
|
|
|
11,479
|
|
(10
|
)
|
—
|
|
—
|
|
||||||||
|
Corporate bonds
|
212,903
|
|
(904
|
)
|
—
|
|
—
|
|
|
153,491
|
|
(280
|
)
|
1,000
|
|
—
|
|
||||||||
|
Municipal debt securities
|
33,902
|
|
(62
|
)
|
1,250
|
|
(1
|
)
|
|
35,625
|
|
(42
|
)
|
4,615
|
|
(5
|
)
|
||||||||
|
Total
|
$
|
313,271
|
|
$
|
(1,392
|
)
|
$
|
1,250
|
|
$
|
(1
|
)
|
|
$
|
223,583
|
|
$
|
(370
|
)
|
$
|
5,615
|
|
$
|
(5
|
)
|
|
|
March 31, 2017
|
|
September 30, 2016
|
||||||||||
|
Range of maturity
|
Amortized Cost
|
Fair Value
|
|
Amortized Cost
|
Fair Value
|
||||||||
|
Due within 1 year
|
$
|
204,708
|
|
$
|
204,655
|
|
|
$
|
135,886
|
|
$
|
135,884
|
|
|
Due in 1 to 2 years
|
219,732
|
|
219,571
|
|
|
225,679
|
|
225,953
|
|
||||
|
Due in 2 to 3 years
|
104,297
|
|
103,570
|
|
|
164,339
|
|
164,583
|
|
||||
|
Total
|
$
|
528,737
|
|
$
|
527,796
|
|
|
$
|
525,904
|
|
$
|
526,420
|
|
|
|
March 31,
2017 |
|
September 30,
2016 |
||||
|
Land
|
$
|
43,270
|
|
|
$
|
43,325
|
|
|
Buildings and building improvements
|
276,916
|
|
|
251,700
|
|
||
|
Leasehold improvements
|
61,626
|
|
|
60,480
|
|
||
|
Machinery and equipment
|
94,917
|
|
|
88,943
|
|
||
|
Computer equipment and software
|
162,883
|
|
|
154,291
|
|
||
|
Furniture and fixtures
|
27,735
|
|
|
26,900
|
|
||
|
Equipment provided under operating leases
|
73,912
|
|
|
35,968
|
|
||
|
Construction-in-progress
|
6,520
|
|
|
32,576
|
|
||
|
Property, plant and equipment, gross
|
747,779
|
|
|
694,183
|
|
||
|
Less: accumulated depreciation
|
(276,684
|
)
|
|
(250,527
|
)
|
||
|
Property, plant and equipment, net
|
$
|
471,095
|
|
|
$
|
443,656
|
|
|
|
Goodwill
|
||
|
Balance at September 30, 2016
|
$
|
309,616
|
|
|
Translation adjustments
|
(865
|
)
|
|
|
Balance at March 31, 2017
|
$
|
308,751
|
|
|
|
March 31, 2017
|
|
September 30, 2016
|
||||||||||||||||
|
Intangible Assets, Net
|
Cost
|
Accumulated
Amortization
|
Net
|
|
Cost
|
Accumulated
Amortization
|
Net
|
||||||||||||
|
Acquired patents and technology
|
$
|
298,556
|
|
$
|
(115,122
|
)
|
$
|
183,434
|
|
|
$
|
293,824
|
|
$
|
(101,711
|
)
|
$
|
192,113
|
|
|
Customer relationships
|
56,803
|
|
(37,006
|
)
|
19,797
|
|
|
56,821
|
|
(34,113
|
)
|
22,708
|
|
||||||
|
Other intangibles
|
22,694
|
|
(22,202
|
)
|
492
|
|
|
22,716
|
|
(22,195
|
)
|
521
|
|
||||||
|
Total
|
$
|
378,053
|
|
$
|
(174,330
|
)
|
$
|
203,723
|
|
|
$
|
373,361
|
|
$
|
(158,019
|
)
|
$
|
215,342
|
|
|
Fiscal Period
|
Total Purchase Consideration
(1)
|
Weighted-Average
Useful Life
|
|
|
(in millions)
|
(in years)
|
|
Fiscal 2016
|
|
|
|
Q1 - Quarter ended January 1, 2016
|
$105.3
|
9.0
|
|
Q2 - Quarter ended April 1, 2016
|
None
|
|
|
|
$105.3
|
9.0
|
|
Fiscal 2017
|
|
|
|
Q1 - Quarter ended December 30, 2016
|
None
|
|
|
Q2 - Quarter ended March 31, 2017
|
$5.3
|
18.0
|
|
|
$5.3
|
18.0
|
|
Fiscal Year
|
Amortization Expense
|
||
|
Remainder of 2017
|
$
|
14,076
|
|
|
2018
|
25,592
|
|
|
|
2019
|
25,008
|
|
|
|
2020
|
24,545
|
|
|
|
2021
|
24,518
|
|
|
|
Thereafter
|
89,984
|
|
|
|
Total
|
$
|
203,723
|
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
Weighted-Average
Remaining
Contractual Life
|
Aggregate
Intrinsic
Value
(1)
|
|||||
|
|
(in thousands)
|
|
(in years)
|
(in thousands)
|
|||||
|
Options outstanding at September 30, 2016
|
8,690
|
|
$
|
35.98
|
|
|
|
||
|
Grants
|
1,959
|
|
46.05
|
|
|
|
|||
|
Exercises
|
(567
|
)
|
33.06
|
|
|
|
|||
|
Forfeitures and cancellations
|
(69
|
)
|
37.70
|
|
|
|
|||
|
Options outstanding at March
31, 2017
|
10,013
|
|
38.10
|
|
7.1
|
$
|
143,411
|
|
|
|
Options vested and expected to vest at March
31, 2017
|
9,268
|
|
37.84
|
|
7.0
|
135,212
|
|
||
|
Options exercisable at March
31, 2017
|
5,195
|
|
$
|
35.55
|
|
6.0
|
87,726
|
|
|
|
(1)
|
Aggregate intrinsic value is based on the closing price of our Class A common stock on
March 31, 2017
of
$52.41
and excludes the impact of options that were not in-the-money.
|
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||
|
|
(in thousands)
|
|
|||
|
Non-vested at September
30, 2016
|
2,872
|
|
$
|
40.16
|
|
|
Granted
|
1,091
|
|
46.15
|
|
|
|
Vested
|
(1,000
|
)
|
36.24
|
|
|
|
Forfeitures
|
(63
|
)
|
39.18
|
|
|
|
Non-vested at
March
31, 2017
|
2,900
|
|
$
|
43.79
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||
|
Expected term (in years)
|
5.13
|
|
5.24
|
|
|
5.13
|
|
5.24
|
|
|
Risk-free interest rate
|
1.9
|
%
|
1.5
|
%
|
|
2.1
|
%
|
1.7
|
%
|
|
Expected stock price volatility
|
27.0
|
%
|
30.1
|
%
|
|
27.5
|
%
|
29.8
|
%
|
|
Dividend yield
|
1.2
|
%
|
1.4
|
%
|
|
1.1
|
%
|
1.4
|
%
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Compensation Expense - By Type
|
|
|
|
|
|
||||||||
|
Stock options
|
$
|
4,575
|
|
$
|
4,998
|
|
|
$
|
9,378
|
|
$
|
11,364
|
|
|
Restricted stock units
|
10,514
|
|
10,267
|
|
|
22,097
|
|
22,343
|
|
||||
|
Employee stock purchase plan
|
894
|
|
821
|
|
|
1,723
|
|
1,759
|
|
||||
|
Total stock-based compensation
|
15,983
|
|
16,086
|
|
|
33,198
|
|
35,466
|
|
||||
|
Benefit from income taxes
|
(4,635
|
)
|
(4,706
|
)
|
|
(9,663
|
)
|
(10,412
|
)
|
||||
|
Total stock-based compensation, net of tax
|
$
|
11,348
|
|
$
|
11,380
|
|
|
$
|
23,535
|
|
$
|
25,054
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Compensation Expense - By Classification
|
|
|
|
|
|||||||||
|
Cost of products
|
$
|
223
|
|
$
|
219
|
|
|
$
|
481
|
|
$
|
499
|
|
|
Cost of services
|
123
|
|
114
|
|
|
257
|
|
243
|
|
||||
|
Research and development
|
4,506
|
|
4,268
|
|
|
9,436
|
|
9,375
|
|
||||
|
Sales and marketing
|
6,509
|
|
6,441
|
|
|
13,376
|
|
14,151
|
|
||||
|
General and administrative
|
4,622
|
|
5,044
|
|
|
9,648
|
|
11,198
|
|
||||
|
Total stock-based compensation
|
15,983
|
|
16,086
|
|
|
33,198
|
|
35,466
|
|
||||
|
Benefit from income taxes
|
(4,635
|
)
|
(4,706
|
)
|
|
(9,663
|
)
|
(10,412
|
)
|
||||
|
Total stock-based compensation, net of tax
|
$
|
11,348
|
|
$
|
11,380
|
|
|
$
|
23,535
|
|
$
|
25,054
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Tax benefit - shares issued under ESPP
|
$
|
95
|
|
$
|
28
|
|
|
$
|
419
|
|
$
|
123
|
|
|
Authorization Period
|
Authorization Amount
|
||
|
Fiscal 2010: November 2009
|
$
|
250,000
|
|
|
Fiscal 2010: July 2010
|
300,000
|
|
|
|
Fiscal 2011: July 2011
|
250,000
|
|
|
|
Fiscal 2012: February 2012
|
100,000
|
|
|
|
Fiscal 2015: October 2014
|
200,000
|
|
|
|
Fiscal 2017: January 2017
|
200,000
|
|
|
|
Total
|
$
|
1,300,000
|
|
|
Quarterly Repurchase Activity
|
Shares
Repurchased
|
Cost
(1)
|
Average Price Paid Per Share
(2)
|
|||||
|
|
|
(in thousands)
|
|
|||||
|
Q1 - Quarter ended December 30, 2016
|
531,465
|
|
$
|
25,001
|
|
$
|
47.02
|
|
|
Q2 - Quarter ended March 31, 2017
|
519,917
|
|
24,999
|
|
48.07
|
|
||
|
Total
|
1,051,382
|
|
$
|
50,000
|
|
|
||
|
(1)
|
Cost of share repurchases includes the price paid per share and applicable commissions.
|
|
(2)
|
Average price paid per share excludes commission costs.
|
|
Fiscal Period
|
Declaration Date
|
Record Date
|
Payment Date
|
Cash Dividend Per Common Share
|
Dividend Payment
|
|
||
|
Fiscal 2017
|
|
|
|
|
|
|
||
|
Q1 - Quarter ended December 30, 2016
|
January 25, 2017
|
February 6, 2017
|
February 15, 2017
|
$
|
0.14
|
|
$14.3 million
|
|
|
Q2 - Quarter ended March 31, 2017
|
April 26, 2017
|
May 8, 2017
|
May 16, 2017
|
$
|
0.14
|
|
$14.3 million
|
(1)
|
|
(1)
|
The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.
|
|
|
Fiscal Quarter Ended
March 31, 2017
|
|
Fiscal Year-To-Date Ended
March 31, 2017
|
||||||||||||||||
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
||||||||||||
|
Beginning Balance
|
$
|
(1,277
|
)
|
$
|
(18,402
|
)
|
$
|
(19,679
|
)
|
|
$
|
742
|
|
$
|
(10,939
|
)
|
$
|
(10,197
|
)
|
|
Other comprehensive income/(loss) before reclassifications:
|
|
|
|
|
|
|
|
||||||||||||
|
Unrealized gains/(losses) - investment securities
|
686
|
|
|
686
|
|
|
(1,474
|
)
|
|
(1,474
|
)
|
||||||||
|
Foreign currency translation gains/(losses)
(1)
|
|
4,989
|
|
4,989
|
|
|
|
(3,739
|
)
|
(3,739
|
)
|
||||||||
|
Income tax effect - benefit/(expense)
|
(99
|
)
|
(599
|
)
|
(698
|
)
|
|
3
|
|
666
|
|
669
|
|
||||||
|
Net of tax
|
587
|
|
4,390
|
|
4,977
|
|
|
(1,471
|
)
|
(3,073
|
)
|
(4,544
|
)
|
||||||
|
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
||||||||||||
|
Realized gains/(losses) - investment securities
(1)
|
(12
|
)
|
|
(12
|
)
|
|
34
|
|
|
34
|
|
||||||||
|
Income tax effect - benefit/(expense)
(2)
|
6
|
|
|
6
|
|
|
(1
|
)
|
|
(1
|
)
|
||||||||
|
Net of tax
|
(6
|
)
|
—
|
|
(6
|
)
|
|
33
|
|
—
|
|
33
|
|
||||||
|
Net current-period other comprehensive (loss)
|
581
|
|
4,390
|
|
4,971
|
|
|
(1,438
|
)
|
(3,073
|
)
|
(4,511
|
)
|
||||||
|
Ending Balance
|
$
|
(696
|
)
|
$
|
(14,012
|
)
|
$
|
(14,708
|
)
|
|
$
|
(696
|
)
|
$
|
(14,012
|
)
|
$
|
(14,708
|
)
|
|
|
Fiscal Quarter Ended
April 1, 2016
|
|
Fiscal Year-To-Date Ended
April 1, 2016
|
||||||||||||||||
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
||||||||||||
|
Beginning Balance
|
$
|
(510
|
)
|
$
|
(12,413
|
)
|
$
|
(12,923
|
)
|
|
$
|
350
|
|
$
|
(11,812
|
)
|
$
|
(11,462
|
)
|
|
Other comprehensive income/(loss) before reclassifications:
|
|
|
|
|
|
|
|
||||||||||||
|
Unrealized gains - investment securities
|
1,401
|
|
|
1,401
|
|
|
242
|
|
|
242
|
|
||||||||
|
Foreign currency translation gains
(1)
|
|
3,173
|
|
3,173
|
|
|
|
2,229
|
|
2,229
|
|
||||||||
|
Income tax effect - benefit/(expense)
|
(94
|
)
|
(155
|
)
|
(249
|
)
|
|
105
|
|
188
|
|
293
|
|
||||||
|
Net of tax
|
1,307
|
|
3,018
|
|
4,325
|
|
|
347
|
|
2,417
|
|
2,764
|
|
||||||
|
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
||||||||||||
|
Realized gains - investment securities
(1)
|
347
|
|
|
347
|
|
|
478
|
|
|
478
|
|
||||||||
|
Income tax effect - (expense)
(2)
|
(91
|
)
|
|
(91
|
)
|
|
(122
|
)
|
|
(122
|
)
|
||||||||
|
Net of tax
|
256
|
|
—
|
|
256
|
|
|
356
|
|
—
|
|
356
|
|
||||||
|
Net current-period other comprehensive income
|
1,563
|
|
3,018
|
|
4,581
|
|
|
703
|
|
2,417
|
|
3,120
|
|
||||||
|
Ending Balance
|
$
|
1,053
|
|
$
|
(9,395
|
)
|
$
|
(8,342
|
)
|
|
$
|
1,053
|
|
$
|
(9,395
|
)
|
$
|
(8,342
|
)
|
|
(1)
|
Realized gains or losses from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/expense, net in our consolidated statements of operations.
|
|
(2)
|
The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Numerator:
|
|
|
|
|
|
||||||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
50,590
|
|
$
|
67,398
|
|
|
$
|
103,964
|
|
$
|
98,299
|
|
|
|
|
|
|
|
|
||||||||
|
Denominator:
|
|
|
|
|
|
||||||||
|
Weighted-average shares outstanding—basic
|
101,787
|
|
100,456
|
|
|
101,635
|
|
100,600
|
|
||||
|
Potential common shares from options to purchase common stock
|
1,513
|
|
748
|
|
|
1,448
|
|
674
|
|
||||
|
Potential common shares from restricted stock units
|
583
|
|
351
|
|
|
784
|
|
442
|
|
||||
|
Weighted-average shares outstanding—diluted
|
103,883
|
|
101,555
|
|
|
103,867
|
|
101,716
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Net income per share attributable to Dolby Laboratories, Inc.:
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.50
|
|
$
|
0.67
|
|
|
$
|
1.02
|
|
$
|
0.98
|
|
|
Diluted
|
$
|
0.49
|
|
$
|
0.66
|
|
|
$
|
1.00
|
|
$
|
0.97
|
|
|
|
|
|
|
|
|
||||||||
|
Antidilutive awards excluded from calculation:
|
|
|
|
|
|
||||||||
|
Stock options
|
1,819
|
|
7,124
|
|
|
1,222
|
|
6,349
|
|
||||
|
Restricted stock units
|
2
|
|
733
|
|
|
8
|
|
184
|
|
||||
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
||||||||
|
Withholding taxes
|
$
|
13,408
|
|
$
|
12,406
|
|
|
$
|
22,399
|
|
$
|
22,188
|
|
|
|
Payments Due By Fiscal Period
|
||||||||||||||||||||
|
|
Remainder Of
Fiscal 2017 |
Fiscal
2018 |
Fiscal
2019 |
Fiscal
2020 |
Fiscal
2021 |
Thereafter
|
Total
|
||||||||||||||
|
Naming rights
|
$
|
—
|
|
$
|
7,715
|
|
$
|
7,811
|
|
$
|
7,909
|
|
$
|
8,008
|
|
$
|
94,972
|
|
$
|
126,415
|
|
|
Donation commitments
|
—
|
|
6,300
|
|
322
|
|
322
|
|
122
|
|
1,013
|
|
8,079
|
|
|||||||
|
Operating leases
|
8,030
|
|
14,411
|
|
11,865
|
|
11,108
|
|
9,809
|
|
33,520
|
|
88,743
|
|
|||||||
|
Purchase obligations
|
7,579
|
|
8,300
|
|
24,289
|
|
21,010
|
|
—
|
|
—
|
|
61,178
|
|
|||||||
|
Total
|
$
|
15,609
|
|
$
|
36,726
|
|
$
|
44,287
|
|
$
|
40,349
|
|
$
|
17,939
|
|
$
|
129,505
|
|
$
|
284,415
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
Revenue
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
|
Licensing
|
90%
|
91%
|
|
89%
|
89%
|
|
Products
|
8%
|
7%
|
|
9%
|
9%
|
|
Services
|
2%
|
2%
|
|
2%
|
2%
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
Fiscal Year-To-Date Ended
|
|
|
Revenue By Geographic Location
|
March 31,
2017 |
April 1,
2016 |
|
United States
|
32%
|
29%
|
|
International
|
68%
|
71%
|
|
Technology
|
Description
|
|
AAC & HE-AAC
|
An advanced digital audio codec solution with higher bandwidth efficiency used for a wide range of media applications such as TVs, STBs, PCs, gaming consoles, mobile devices and digital radio.
|
|
AVC
|
A digital video codec with high bandwidth efficiency used in a wide range of media devices, such as TVs, STBs, PCs, gaming consoles, and mobile devices.
|
|
Dolby® AC-4
|
A next-generation digital audio coding technology that is aimed at maximizing transmission efficiency while delivering new audio experiences to a wide range of playback devices, including TVs, STBs, PCs, and mobile devices.
|
|
Dolby Atmos®
|
An object-oriented audio technology for home theaters, cinema, device speakers, and headphones that allows sound to be precisely placed and moved anywhere in the listening environment including the overhead dimension. Dolby Atmos is an immersive experience that can be provided via multiple Dolby audio coding technologies.
|
|
Dolby Digital®
|
A digital audio coding technology that provides multichannel sound to applications such as DVD players, TVs and STBs.
|
|
Dolby Digital Plus™
|
An advanced digital audio coding technology that offers more efficient audio transmission for a wide range of media applications such as TVs, STBs, Blu-ray Discs, PCs, and mobile devices.
|
|
Dolby® TrueHD
|
A digital audio coding technology providing lossless encoding for premium quality media applications such as Blu-ray Discs and home theaters.
|
|
Dolby Vision™
|
An imaging technology combining HDR and an expanded color spectrum to deliver higher contrast, brighter highlights, and improved details for TV, cinema, and other consumer devices.
|
|
Dolby Voice®
|
An audio conferencing technology with superior spatial perception, voice clarity and background noise reduction that emulates the in-person meeting experience.
|
|
HEVC
|
A next-generation digital video codec with higher bandwidth efficiency to support ultra-high definition experiences for a wide range of media devices.
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
|
||
|
Market
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
Main Offerings Incorporating Our Technologies
|
|
Broadcast
|
44%
|
45%
|
|
45%
|
46%
|
STBs & Televisions
|
|
PC
|
15%
|
16%
|
|
15%
|
16%
|
Windows and macOS operating systems
|
|
CE
|
15%
|
14%
|
|
13%
|
14%
|
DMAs, Blu-ray Disc devices, AVRs, soundbars, DVDs & HTIBs
|
|
Mobile
|
11%
|
11%
|
|
11%
|
10%
|
Smartphones & tablets
|
|
Other
|
15%
|
14%
|
|
16%
|
14%
|
Gaming consoles, Auto DVD, Dolby Cinema, Dolby Voice
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
Product
|
Description
|
|
|
Cinema
|
Digital Cinema Servers
|
Servers used to load, store, decrypt, decode and watermark digital film files for presentation on digital cinema projectors, and also encrypt, encode and package digital film data for distribution.
|
|
Cinema Audio Products
|
Cinema Processors used to decode and render digital cinema soundtracks including those using Dolby Atmos and products that author, encrypt, encode and package Dolby Atmos soundtracks.
|
|
|
Other
|
Dolby Conference Phone
|
An integral hardware component of the Dolby Voice conferencing solution that enhances productivity through superior sound, full-room voice capture, spatial voice separation and touch-screen interface.
|
|
Other Products
|
3-D glasses and kits, broadcast hardware and software used to encode, transmit, and decode multiple channels of high quality audio for DTV and HDTV distribution, monitors, and accessibility solutions for hearing and visually impaired consumers.
|
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Licensing
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
Revenue
|
$241,617
|
$249,336
|
$(7,719)
|
(3)%
|
|
$474,316
|
$460,465
|
$13,851
|
3%
|
|
Percentage of total revenue
|
90%
|
91%
|
|
|
|
89%
|
89%
|
|
|
|
Cost of licensing
|
8,796
|
6,698
|
2,098
|
31%
|
|
16,917
|
13,231
|
3,686
|
28%
|
|
Gross margin
|
232,821
|
242,638
|
(9,817)
|
(4)%
|
|
457,399
|
447,234
|
10,165
|
2%
|
|
Gross margin percentage
|
96%
|
97%
|
|
|
|
96.43%
|
97%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Broadcast
|
â
|
Lower recoveries, partially offset by higher STB units reported
|
â
|
Increase in cost of licensing primarily due to higher depreciation of Dolby Cinema equipment and amortization of newly-acquired assets
|
|
PC
|
â
|
Decrease primarily due to timing of revenue under contractual arrangements and lower recoveries
|
||
|
CE
|
á
|
Higher recoveries, higher revenue from patent licensing and higher shipments of soundbars and DMAs, partially offset by decreases due to timing of revenue under contractual arrangements and lower shipments of DVD players and HTIBs
|
||
|
Other
|
ßà
|
Higher revenues from automotive recoveries and Dolby Cinema, offset by lower revenue from Via Licensing and lower shipments of gaming consoles
|
||
|
Mobile
|
ßà
|
No significant fluctuations
|
||
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Other
|
á
|
Higher revenues from automotive recoveries and Dolby Cinema
|
â
|
Increase in cost of licensing primarily due to higher depreciation of Dolby Cinema equipment and amortization of newly-acquired assets
|
|
Mobile
|
á
|
Higher revenue from patent licensing programs, including new customers, partially offset by lower units reported
|
||
|
PC
|
â
|
Decrease due to timing of revenue under contractual arrangements, partially offset by higher units reported, higher revenue from patent licensing and higher recoveries
|
||
|
Broadcast
|
á
|
Higher STB units reported, partially offset by lower recoveries and pricing
|
||
|
CE
|
â
|
Lower shipments of DVD players, HTIBs and Blu-ray, partially offset by higher recoveries, revenue from patent licensing, and higher shipments of soundbars
|
||
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Products
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
Revenue
|
$20,713
|
$20,063
|
$650
|
3%
|
|
$48,924
|
$44,872
|
$4,052
|
9%
|
|
Percentage of total revenue
|
8%
|
7%
|
|
|
|
9%
|
9%
|
|
|
|
Cost of products
|
13,988
|
13,978
|
10
|
—%
|
|
31,708
|
33,016
|
(1,308)
|
(4)%
|
|
Gross margin
|
6,725
|
6,085
|
640
|
11%
|
|
17,216
|
11,856
|
5,360
|
45%
|
|
Gross margin percentage
|
32%
|
30%
|
|
|
|
35%
|
26%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Cinema
|
á
|
Higher units of digital server and audio products, partially offset by lower units of 3D glasses
|
á
|
Lower manufacturing costs partially offset by a less favorable product mix
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Cinema
|
á
|
Higher units of digital server and audio products and higher sales from extended warranty programs, partially offset by lower units of 3D glasses
|
á
|
Improved mix of products combined with lower manufacturing costs and lower charges from excess & obsolete inventory
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Services
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
Revenue
|
$5,144
|
$4,941
|
$203
|
4%
|
|
$10,501
|
$9,817
|
$684
|
7%
|
|
Percentage of total revenue
|
2%
|
2%
|
|
|
|
2%
|
2%
|
|
|
|
Cost of services
|
4,193
|
3,697
|
496
|
13%
|
|
8,319
|
7,892
|
427
|
5%
|
|
Gross margin
|
951
|
1,244
|
(293)
|
(24)%
|
|
2,182
|
1,925
|
257
|
13%
|
|
Gross margin percentage
|
18%
|
25%
|
|
|
|
21%
|
20%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Configuration & Post-Production
|
ßà
|
No significant fluctuations
|
ßà
|
No significant fluctuations
|
|
Support & Other
|
||||
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Configuration & Post-Production
|
ßà
|
No significant fluctuations
|
ßà
|
No significant fluctuations
|
|
Support & Other
|
||||
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
Research and development
|
$58,341
|
$52,088
|
$6,253
|
12%
|
|
$115,859
|
$105,416
|
$10,443
|
10%
|
|
Percentage of total revenue
|
22%
|
19%
|
|
|
|
22%
|
20%
|
|
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher headcount on new or existing R&D projects along with merit increases across the employee base
|
|
Product Development
|
á
|
Increased funding of various research projects and initiatives aimed at developing new products and technologies
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher headcount on new or existing R&D projects along with merit increases across the employee base
|
|
Product Development
|
á
|
Increased funding of various research projects and initiatives aimed at developing new products and technologies
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
Sales and marketing
|
$75,620
|
$71,815
|
$3,805
|
5%
|
|
$146,795
|
$146,269
|
$526
|
—%
|
|
Percentage of total revenue
|
28%
|
26%
|
|
|
|
28%
|
28%
|
|
|
|
Category
|
Key Drivers
|
|
|
Marketing Programs
|
á
|
Increase impacted by the timing of promotional events and other marketing activities
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base
|
|
Marketing Programs
|
â
|
Decrease impacted by the timing of promotional events and other marketing activities, partially offset by higher costs associated with industry trade shows
|
|
Technology & Communications
|
â
|
Lower costs associated with IT-related projects
|
|
Stock-Based Compensation
|
â
|
Decrease in award grants
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
General and administrative
|
$43,253
|
$42,482
|
$771
|
2%
|
|
$84,793
|
$86,560
|
$(1,767)
|
(2)%
|
|
Percentage of total revenue
|
16%
|
15%
|
|
|
|
16%
|
17%
|
|
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base
|
|
Legal, Professional & Consulting
|
á
|
Higher costs associated with patent filings and other various legal activities
|
|
Facilities
|
â
|
Lower proportionate costs associated with our headquarters
|
|
Category
|
Key Drivers
|
|
|
Stock-Based Compensation
|
â
|
Decrease in award grants
|
|
Facilities
|
â
|
Lower proportionate costs associated with our headquarters
|
|
Compensation & Benefits
|
á
|
Higher headcount and merit increases across the existing employee base
|
|
|
Fiscal Quarter Ended
|
Change
|
|
Fiscal Year-To-Date Ended
|
Change
|
||||
|
Other Income/Expense
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
March 31,
2017 |
April 1,
2016 |
$
|
%
|
|
Interest income
|
$2,186
|
$1,250
|
$936
|
75%
|
|
$4,000
|
$2,547
|
$1,453
|
57%
|
|
Interest expense
|
(37)
|
(33)
|
(4)
|
12%
|
|
(63)
|
(62)
|
(1)
|
2%
|
|
Other income/(expense), net
|
762
|
279
|
483
|
173%
|
|
563
|
(693)
|
1,256
|
(181)%
|
|
Total
|
$2,911
|
$1,496
|
$1,415
|
95%
|
|
$4,500
|
$1,792
|
$2,708
|
151%
|
|
Category
|
Key Drivers
|
|
|
Interest Income
|
á
|
Increase due to higher yields on our investment balances
|
|
Category
|
Key Drivers
|
|
|
Interest Income
|
á
|
Increase due to higher yields on our investment balances
|
|
Other Income/(Expense)
|
á
|
Decrease in other expense due primarily to lower currency translation losses and other expenses
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
|
March 31,
2017 |
April 1,
2016 |
|
March 31,
2017 |
April 1,
2016 |
|
Provision for income taxes
|
$(15,467)
|
$(16,278)
|
|
$(29,549)
|
$(24,751)
|
|
Effective tax rate
|
23.4%
|
19.4%
|
|
22.1%
|
20.1%
|
|
Factor
|
Impact On Effective Tax Rate
|
|
|
Tax Contingencies
|
á
|
Decreased benefit from the settlement of a state audit in the prior year
|
|
Foreign Operations
|
â
|
Increased benefit from foreign earned income
|
|
Factor
|
Impact On Effective Tax Rate
|
|
|
Tax Contingencies
|
á
|
Decreased benefit from the settlement of a state audit in the prior year
|
|
Federal R&D Credits
|
á
|
Decrease in discrete benefits from federal R&D credits
|
|
Foreign Operations
|
â
|
Increased benefit from foreign earned income
|
|
|
March 31,
2017 |
September 30,
2016 |
||||
|
Cash and cash equivalents
|
$
|
532,508
|
|
$
|
516,112
|
|
|
Short-term investments
|
194,997
|
|
121,629
|
|
||
|
Long-term investments
|
326,800
|
|
393,904
|
|
||
|
Accounts receivable, net
|
88,216
|
|
75,688
|
|
||
|
Accounts payable and accrued liabilities
|
189,091
|
|
186,599
|
|
||
|
Working capital
|
658,615
|
|
546,647
|
|
||
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
March 31,
2017 |
April 1,
2016 |
||||
|
Net cash provided by operating activities
|
$
|
155,347
|
|
$
|
156,866
|
|
|
Factor
|
Impact On Cash Flows
|
|
|
Net Income
|
â
|
Higher net income, more than offset by non-cash reconciling adjustments
|
|
Working Capital
|
â
|
Net overall decrease primarily attributed to an increase in accounts receivable and decrease in deferred revenue, partially offset by an increase in income tax liabilities
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
March 31,
2017 |
April 1,
2016 |
||||
|
Net cash used in investing activities
|
$
|
(68,134
|
)
|
$
|
(71,393
|
)
|
|
Capital expenditures
|
(51,230
|
)
|
(48,984
|
)
|
||
|
Factor
|
Impact On Cash Flows
|
|
|
Proceeds From Investments
|
â
|
Lower inflows from the sale & maturity of marketable investment securities
|
|
Purchase Of Investments
|
á
|
Lower outflows for the purchase of marketable investment securities
|
|
Acquisition Of Intangible Assets
|
á
|
Lower outflows for the purchase of patent portfolios
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
March 31,
2017 |
April 1,
2016 |
||||
|
Net cash used in financing activities
|
$
|
(68,196
|
)
|
$
|
(97,099
|
)
|
|
Repurchase of common stock
|
(50,000
|
)
|
(76,856
|
)
|
||
|
Factor
|
Impact On Cash Flows
|
|
|
Share Repurchases
|
á
|
Lower outflows from decreases in common stock repurchases
|
|
•
|
Australian Dollar
|
|
•
|
British Pound
|
|
•
|
Chinese Yuan
|
|
•
|
Euro
|
|
•
|
Indian Rupee
|
|
•
|
Japanese Yen
|
|
•
|
Korean Won
|
|
•
|
Polish Zloty
|
|
•
|
Russian Ruble
|
|
•
|
Swedish Krona
|
|
•
|
Purchasing trends away from traditional PCs and toward computing devices without optical disc drives, such as ultrabooks and tablets, which trends we expect to continue;
|
|
•
|
Because PC OEMs are required to pay us a higher per-unit royalty for Windows 8 and Windows 10 PCs that include optical disc playback functionality than Windows 8 or Windows 10 PCs that do not include such functionality, the continued decreasing inclusion of optical disc drives in Windows 8 or Windows 10 PCs will result in lower per-unit royalties;
|
|
•
|
PC software that includes our technologies on an unauthorized and infringing basis, for which we receive no royalty payments; and
|
|
•
|
Continued decreasing inclusion of independent software vendor media applications by PC OEMs.
|
|
•
|
Exhibitors may choose competing products with different features or lower prices; and
|
|
•
|
Pricing and other competitive pressures have caused us to implement pricing strategies which have adversely affected gross margins of our cinema products.
|
|
•
|
Timing of royalty reports from our licensees and meeting revenue recognition criteria;
|
|
•
|
Royalty reports including positive or negative corrective adjustments;
|
|
•
|
Retroactive royalties that cover extended periods of time; and
|
|
•
|
Timing of revenue recognition under licensing agreements and other contractual arrangements, including recognition of unusually large amounts of revenue in any given quarter because not all of our revenue recognition criteria were met in prior periods.
|
|
•
|
Rapid technological change;
|
|
•
|
New and improved technology and frequent product introductions;
|
|
•
|
Changing consumer and licensee demands;
|
|
•
|
Evolving industry standards; and
|
|
•
|
Technology and product obsolescence.
|
|
•
|
Possibility that innovations may not be protectable;
|
|
•
|
Failure to protect innovations that later turn out to be important;
|
|
•
|
Insufficient patent protection to prevent third parties from designing around our patent claims;
|
|
•
|
Our pending patent applications may not be approved; and
|
|
•
|
Possibility that an issued patent may later be found to be invalid or unenforceable.
|
|
•
|
Our ability to enforce our contractual and IP rights, especially in countries that do not recognize and
|
|
•
|
Limited or no patent protection for our DD technologies in countries such as China, Taiwan, and India, which may require us to obtain patent rights for new and existing technologies in order to grow or maintain our revenue; and
|
|
•
|
Because of limitations in the legal systems in many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our IP and contractual rights without relying solely on the legal systems in the countries in which we operate.
|
|
•
|
Content creators, such as film directors, studios, music producers and mobile and online content producers;
|
|
•
|
Content distributors, such as film exhibitors, broadcasters, operators, and OTT video service providers and video game publishers; and
|
|
•
|
Device manufacturers.
|
|
•
|
Diversion of management time and focus from operating our business to acquisition integration challenges;
|
|
•
|
Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization;
|
|
•
|
Retaining employees, suppliers and customers from businesses we acquire;
|
|
•
|
The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
|
|
•
|
Possible write-offs or impairment charges resulting from acquisitions;
|
|
•
|
Unanticipated or unknown liabilities relating to acquired businesses; and
|
|
•
|
The need to integrate acquired businesses’ accounting, management information, manufacturing, human resources, and other administrative systems to permit effective management.
|
|
•
|
U.S. and foreign government trade restrictions, including those which may impose restrictions on importation of programming, technology, or components to or from the U.S.;
|
|
•
|
Compliance with applicable international laws and regulations, including antitrust laws, that may change unexpectedly, differ, or conflict with laws in other countries where we conduct business, or are otherwise not harmonized with one another;
|
|
•
|
Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
|
|
•
|
Changes in diplomatic and trade relationships, including new tariffs, trade protection measures, import or export licensing requirements, trade embargoes and other trade barriers;
|
|
•
|
Difficulty in establishing, staffing, and managing foreign operations;
|
|
•
|
Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
|
|
•
|
Poor recognition of IP rights;
|
|
•
|
Difficulties in enforcing contractual rights;
|
|
•
|
Political or social instability, natural disasters, war or events of terrorism; and
|
|
•
|
The strength of international economies.
|
|
•
|
Earnings being lower than anticipated in countries that have lower tax rates and higher than anticipated in countries that have higher tax rates;
|
|
•
|
Changes in the valuation of our deferred tax assets and liabilities;
|
|
•
|
Transfer pricing adjustments;
|
|
•
|
Tax effects of nondeductible compensation;
|
|
•
|
Tax costs related to intercompany realignments;
|
|
•
|
Any obligations or decisions to repatriate earnings from abroad earlier than anticipated;
|
|
•
|
Changes in accounting principles; or
|
|
•
|
Changes in tax laws and regulations in the countries in which we operate, including U.S. legislative changes.
|
|
Repurchase Activity
|
Total Shares Repurchased
|
Average Price
Paid Per Share (1) |
Total Shares Purchased As Part Of Publicly Announced Programs
|
Remaining Authorized Share Repurchases
(2)
|
|
December 31, 2016 - January 27, 2017
|
—
|
$—
|
—
|
$226.9 million
|
|
January 28, 2017 - February 24, 2017
|
519,917
|
48.07
|
519,917
|
$201.9 million
|
|
February 25, 2017 - March 31, 2017
|
—
|
—
|
—
|
$201.9 million
|
|
Total
|
519,917
|
|
519,917
|
|
|
(1)
|
Average price paid per share excludes commission costs.
|
|
(2)
|
Amounts represent the approximate dollar value of the maximum remaining number of shares that may yet be purchased under the stock repurchase program, and excludes commission costs.
|
|
Exhibit
Number
|
|
Description
|
|
Incorporated By Reference Herein
|
|
|
||||
|
|
Form
|
|
File Number
|
|
Date
|
|
Provided Herewith
|
|||
|
10.1*
|
|
2005 Stock Plan (as amended and restated on February 7, 2017)
|
|
Current Report on Form 8–K
|
|
001–32431
|
|
February 9, 2017
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
32.1+
|
|
Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
101.DEF
|
|
XBRL Extension Definition
|
|
|
|
|
|
|
|
X
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
DOLBY LABORATORIES, INC.
|
|
|
By:
|
/
S
/ LEWIS CHEW
|
|
|
Lewis Chew
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|